Hereditary haemochromatosis: Only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload

Human Genetics

Volumn 111, Issue 6, 2002, Pages 538-543

  McCune, C Anne ^a   Al Jader, Layla N ^b   May, Alison ^a   Hayes, Sara L ^b   Jackson, Helen A ^c   Worwood, Mark ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Iechyd Morgannwg Health ^*  (United Kingdom)

^c ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; EUROPE; FEMALE; GENE MUTATION; GENERAL HOSPITAL; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TEACHING HOSPITAL; TREATMENT PLANNING; UNITED KINGDOM; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; WALES;

EID: 0036944167     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0824-1     Document Type: Article

References (32)

1. Adams PC, Valberg LS (1999) Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 94:1593-1600
2. Adams PC, Gregor JC, Kertesz AE, Valberg LS (1995) Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database. Gastroenterology 109:177-188
3. Adams PC, Deugnier Y, Moirand R, Brissot P (1997) The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 25:162-166
4. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HBG, Sagen E, Bjerve KS (2001) Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 36:1108-1115
5. Beutler E (2001) Discrepancies between genotype and phenotype in hematology: An important frontier. Blood 98:2597-2602
6. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218
7. Bradley LA, Haddow JE, Palomaki GE (1996) Population screening for hemochromatosis: Expectations based on study of relatives of symptomatic patients. J Med Screening 3:171-177
8. Braun J, Donner H, Plock K, Rau H, Usadel KH, Badenhoop K (1998) Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus. Diabetologia 41:983-984
9. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, Edwards CQ, Kushner JP (2000) Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343:1529-1535
10. Burke W, Thomson E, Khoury MJ, Mcdonnell SM, Press N, Adams PC, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS (1998) Hereditary hemochromatosis: Gene discovery and its implications for population-based screening. JAMA 280:172-178
11. Burke W, Imperatone G, McDonnell SM, Baron RC, Khoury MJ (2000) Contribution of different HFE genotypes to iron overload disease: A pooled analysis. Genet Med 2:271-277
12. Dooley J, Worwood M (2000) Guidelines on Diagnosis and Therapy: Genetic haemochromatosis. British Committee for Standards in Haematology. Darwin Medical Communications, Abingdon, Oxford (http://www.bcshguidelines.com/guidelines.asp?tf=Haemato-Oncology)
13. Dunnen JT den, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
14. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M, Petersen P, Schlicting P, Saermark T, Tybjaerg-Hansen A, Birgens H (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study. Lancet 358:1405-1409
15. Feder JN, Gnirke A, Thomas W, Tsuichihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
16. Fernandezreal JM, Vendrell J, Baiget M, Gimferrer E, Ricart W (1999) C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care 22:525-526
17. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DHG (2002) Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 122:281-289
18. Florkowski CM, George PM, Willis JA, Stott MK, Burt MJ, Upton JD, Nesbit J, Walmsley TA, Scott RS (1999) Haemochromatosis gene mutations C282Y and H63D are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Res Clin Pract 43:199-203
19. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT (1998) C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet 351:1933-1934
20. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474-484
21. McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, Yip R (1999) A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment. Am J Med 106:619-624
22. Merryweather-Clarke AT, Worwood M, Parkinson L, Mattock C, Pointon JJ, Shearman JD, Robson KJH (1998) The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 101:369-373
23. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119
24. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718-724
25. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
26. Sampson MJ, Williams T, Heyburn PJ, Greenwood RH, Temple RC, Wimperis JZ, Jennings BA, Willis GA (2000) Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. J Lab Clin Med 135:170-173
27. UK Haemochromatosis Consortium (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 41: 841-844
28. Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ (1997) A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 23:288-291
29. Willis G, Wimperis JZ, Smith KC, Fellows IW, Jennings BA (1999) Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 354:221-222
30. Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, Jennings BA (2000) Incidence of liver disease in people with HFE mutations. Gut 46:401-404
31. Wilson JMG, Junger G (1968) The principles and practice of screening for disease. Public Health Paper no. 34. World Health Organization, Geneva
32. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG (1998) Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysis of multiple-cause mortality data. Ann Intern Med 129:946-953